AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

BTAI · NASDAQ · Biotechnology

BioXcel Therapeutics (BTAI)

Develops neuroscience therapies through a data-driven drug re-innovation model.

$0.1215

Pre-market+0.01 (+11.37%)

At close$0.1091(−20.36%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions40 holders · as of Mar 31, 2026	17.38%	5.44M shares
Insiders8 holders · as of Jun 17, 2026	0.85%	266.3K shares
Strategic holders2 holders · as of Sep 28, 2023	2.19%	685.5K shares
Otherremainder	79.58%	24.91M shares

31.31M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Millennium Management LLCInstitution	6.19%	1.94M	13Fas of Mar 31, 2026
Armistice Capital, LLCInstitution	6.10%	1.91M	13Fas of Mar 31, 2026
BioXcel LLC^1,2Strategic10 percent owner	1.90%	594,040	13Dfiled Sep 28, 2023 ↗
Oaktree Capital Management LPInstitution	0.77%	241,188	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.74%	230,168	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	0.66%	207,339	13Fas of Mar 31, 2026
Jones Financial Companies LLLPInstitution	0.42%	131,789	13Fas of Mar 31, 2026
Man Group PLCInstitution	0.31%	96,473	13Fas of Mar 31, 2026
AllianceBernstein L.P.Insider	0.30%	94,298	13D/Gfiled Feb 14, 2022 ↗
State Street CorpInstitution	0.29%	92,118	13Fas of Mar 31, 2026
BlackRock, Inc.Strategic	0.29%	91,433	13D/Gfiled Feb 3, 2023 ↗
FMR LLCInstitution	0.29%	90,300	13Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution	0.27%	84,921	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	0.27%	84,282	13Fas of Mar 31, 2026
Wiley Bros.-Aintree Capital, LLCInstitution	0.26%	80,864	13Fas of Mar 31, 2026
Vimal MehtaInsiderdirector, officer: CEO and President	0.22%	69,817	Form 4filed Jun 17, 2026 ↗
UBS Group AGInstitution	0.17%	52,788	13Fas of Mar 31, 2026
Oaktree Fund Advisors, LLCInstitution	0.14%	42,913	13Fas of Mar 31, 2026
Hightower Advisors, LLCInstitution	0.13%	41,000	13Fas of Mar 31, 2026
Northern Trust CorpInstitution	0.12%	36,313	13Fas of Mar 31, 2026
Javier RodriguezInsiderofficer: See Remarks	0.09%	26,838	Form 4filed Jun 17, 2026 ↗
Richard I. SteinhartInsiderofficer: Chief Financial Officer	0.08%	26,335	Form 4filed Jun 17, 2026 ↗
Frank YoccaInsiderofficer: Chief Scientific Officer	0.08%	26,210	Form 4filed Jun 17, 2026 ↗
David J. MackInsiderdirector	0.06%	20,317	Form 4filed Nov 3, 2025 ↗
Beacon Pointe Advisors, LLCInstitution	0.06%	18,877	13Fas of Mar 31, 2026

BioXcel LLC's transaction reports restate only vehicles that traded; the 2023 ownership statement (594.0K) is used instead.
BioXcel LLC reports a block also reported by another filer; it is counted once, under that filer.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

40 holders · 5.44M shares · 8 new positions · 17 increased · 7 reduced · 9 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Millennium Management LLC	1.94M	6.19%	+101.6K	May 15, 2026
Armistice Capital, LLC	1.91M	6.10%	+1.91Mnew	May 15, 2026
Oaktree Capital Management LP	241.2K	0.77%	0	May 20, 2026
Geode Capital Management, LLC	230.2K	0.74%	+24.0K	May 15, 2026
Vanguard Capital Management LLC	207.3K	0.66%	+207.3Knew	May 15, 2026
Jones Financial Companies LLLP	131.8K	0.42%	−5.9K	May 15, 2026
Man Group PLC	96.5K	0.31%	+39.6K	May 15, 2026
State Street Corp	92.1K	0.29%	+28.9K	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Integrated Core Strategies (US) LLC	8.40%	1.83M	13G	Feb 9, 2026 ↗
Armistice Capital, LLC	7.05%	1.91M	13G	May 15, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
May 20, 2026	Vimal Mehtadirector, officer: CEO and President	Sale	19,419	$1.09	69,598
May 20, 2026	Richard I. Steinhartofficer: Chief Financial Officer	Sale	6,845	$1.09	26,300
May 20, 2026	Javier Rodriguezofficer: See Remarks	Sale	6,560	$1.08	26,803
May 20, 2026	Frank Yoccaofficer: Chief Scientific Officer	Sale	6,845	$1.09	26,175

CongressHouse and Senate disclosures

Not reported.